Literature DB >> 153069

Release of glycolytic enzymes from cultivated tumor cells.

K Keller, H Kolbe, K Lange, B Zimmermann.   

Abstract

Several types of cultured cells release glycolytic enzymes into their suspending medium. This effect is most obvious with tumor cells, especially with their ascites forms. Erythrocytes do not release glycolytic enzymes. The total extracellular phosphoglucose isomerase activity consists of two components. One part is dissolved in the medium, the other one is sedimentable at 150 X g together with the cells. The latter seems to be localized at the cell surface. At densities of about 10(6) cells/ml maximum activity in the medium is reached within 5--10 min. After that no further release of enzyme activity can be observed. Serum reduces the rate of enzyme release considerably. This effect can be reversed by washing with protein free media. Treatment with trypsin leads to high extracellular phosphoglucose isomerase activities of the cells which originally show low external enzyme activity. Erythrocytes do not show any effect with trypsin, ascites tumor cells do not alter their high extracellular enzyme activity. At a density of 10(5) cells/ml, Yoshida acites tumor cells, cultured in vitro, release about 12% of originally intracellular phosphoglucose isomerase activity by 5 elutions with fresh medium. The process of enzyme release shows a certain selectivity in respect to different glycolytic enzymes. Aldolase exhibits the highest activity in the medium in relation to its homogenate activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 153069     DOI: 10.1007/bf00461650

Source DB:  PubMed          Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol        ISSN: 0084-5353


  11 in total

1.  On the in vitro release of cytoplasmic enzymes from ascites tumor cells as compared with strain L cells.

Authors:  B HOLMBERG
Journal:  Cancer Res       Date:  1961-11       Impact factor: 12.701

2.  Leakage of enzymes from ascites tumor cells.

Authors:  R WU
Journal:  Cancer Res       Date:  1959-12       Impact factor: 12.701

3.  Serum enzymes in disease V. Isocitric dehydrogenase, malic dehydrogenase, and glycolytic enzymes in patients with carcinoma of the breast.

Authors:  A ROSE; M WEST; H J ZIMMERMAN
Journal:  Cancer       Date:  1961 Jul-Aug       Impact factor: 6.860

4.  The mechanisms of alteration in lactic dehydrogenase activity of body fluids.

Authors:  F WROBLEWSKI
Journal:  Ann N Y Acad Sci       Date:  1958-10-13       Impact factor: 5.691

5.  Serum phosphohexose isomerase in cancer. IV. Comparison with serum-phosphoglucomutase activity in metastatic cancer.

Authors:  O BODANSKY
Journal:  Cancer       Date:  1957 Sep-Oct       Impact factor: 6.860

6.  Comparison of phosphohexose isomerase and lactic dehydrogenase activities in plasma, liver, and tumor tissue of tumor-bearing rats.

Authors:  O BODANSKY; J SCHOLLER
Journal:  Cancer Res       Date:  1956-10       Impact factor: 12.701

7.  Elevation of a serum component in neoplastic disease.

Authors:  B R HILL; C LEVI
Journal:  Cancer Res       Date:  1954-08       Impact factor: 12.701

8.  Enzyme activities at the surface of intact Ehrlich tumor cells with albumin in the isotonic assay medium.

Authors:  C O Wernstedt; G K Agren; G Ronquist
Journal:  Cancer Res       Date:  1975-06       Impact factor: 12.701

9.  Leakage as the source of overgrowth stimulating activity in Rous sarcoma transformed cultures.

Authors:  M J Bissell; H Rubin; C Hatié
Journal:  Exp Cell Res       Date:  1971-10       Impact factor: 3.905

10.  Regulatory mechanisms in carbohydrate metabolism. IX. Stimulation of aerobic glycolysis by energy-linked ion transport and inhibition by dextran sulfate.

Authors:  P Scholnick; D Lang; E Racker
Journal:  J Biol Chem       Date:  1973-07-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.